Heterodimerization of p45–p75 Modulates p75 Signaling: Structural Basis and Mechanism of Action

• Marçal Vilar ,

  Contributed equally to this work with: Marçal Vilar, Tsung-Chang Sung

  * E-mail: klee@salk.edu (K.-F.L.); riek@salk.edu (R.R.); mvilar@isciii.es (M.V.)

  Affiliations Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California, United States of America, Neurodegeneration Unit, Chronic Disease Program, Spanish Institute of Health Carlos III, Madrid, Spain

  ⨯
• Tsung-Chang Sung ,

  Contributed equally to this work with: Marçal Vilar, Tsung-Chang Sung

  Affiliation Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California, United States of America

  ⨯
• Zhijiang Chen,

  Affiliation Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California, United States of America

  ⨯
• Irmina García-Carpio,

  Affiliation Neurodegeneration Unit, Chronic Disease Program, Spanish Institute of Health Carlos III, Madrid, Spain

  ⨯
• Eva M. Fernandez,

  Affiliation Neurodegeneration Unit, Chronic Disease Program, Spanish Institute of Health Carlos III, Madrid, Spain

  ⨯
• Jiqing Xu,

  Affiliation Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California, United States of America

  ⨯
• Roland Riek ,

  * E-mail: klee@salk.edu (K.-F.L.); riek@salk.edu (R.R.); mvilar@isciii.es (M.V.)

  Affiliations Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California, United States of America, Laboratory for Physical Chemistry, ETH Zürich, Zürich, Switzerland

  ⨯
• Kuo-Fen Lee

  * E-mail: klee@salk.edu (K.-F.L.); riek@salk.edu (R.R.); mvilar@isciii.es (M.V.)

  Affiliation Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California, United States of America

  ⨯